Department of Epidemiology and the Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD.
Division of Precision Medicine Research, New York University Grossman School of Medicine, New York, NY.
Am Heart J. 2023 Oct;264:49-58. doi: 10.1016/j.ahj.2023.05.014. Epub 2023 Jun 7.
NT-proBNP is an important predictor of mortality but is inversely related to estimated glomerular filtration rate (eGFR). Whether the prognostic value of NT-proBNP is similar at different levels of kidney function is unknown.
We evaluated the association of NT-proBNP with eGFR and its implications for all-cause and cardiovascular mortality risk in the general population.
We included adults without prior cardiovascular disease from the National Health and Nutrition Examination Survey (NHANES) 1999 to 2004. We used linear regression to characterize the cross-sectional associations of NT-proBNP with eGFR. We used Cox regression to assess the prospective associations of NT-proBNP with mortality across categories of eGFR.
Among 11,456 participants (mean age 43 years, 48% female, 71% White, 11% Black), there was an inverse association between NT-proBNP and eGFR, which was stronger in those with more impaired kidney function. Per 15-unit decrease in eGFR, NT-proBNP was 4.3-fold higher for eGFR<30; 1.7-fold higher for eGFR 30 to 60, 1.4-fold higher for eGFR 61 to 90, 1.1-fold higher for eGFR 91 to 120 mL/min/1.73 m. Over a median 17.6 years of follow-up, 2,275 deaths (622 cardiovascular) occurred. Higher NT-proBNP was associated with higher all-cause (HR per doubling of NT-proBNP: 1.20, 95% CI: 1.16-1.25) and cardiovascular mortality (HR: 1.34, 95% CI 1.25-1.44). Associations were similar across eGFR categories (P-interaction >.10). Adults with NT-proBNP≥450 pg/mL and eGFR<60 mL/min/1.73m had 3.4-fold higher all-cause mortality and 5.5-fold higher cardiovascular mortality risk, compared to those with NT-proBNP<125 pg/mL and eGFR>90 mL/min/1.73m.
Despite its strong inverse association with eGFR, NT-proBNP has robust associations with mortality across the full range of kidney function in the general US adult population.
NT-proBNP 是死亡率的重要预测指标,但与估计的肾小球滤过率(eGFR)呈负相关。在不同肾功能水平下,NT-proBNP 的预后价值是否相似尚不清楚。
我们评估了 NT-proBNP 与 eGFR 的关系及其对普通人群全因和心血管死亡率风险的影响。
我们纳入了来自 1999 年至 2004 年全国健康和营养调查(NHANES)的无既往心血管疾病的成年人。我们使用线性回归来描述 NT-proBNP 与 eGFR 的横断面相关性。我们使用 Cox 回归来评估 NT-proBNP 在 eGFR 各分类中与死亡率的前瞻性相关性。
在 11456 名参与者(平均年龄 43 岁,48%为女性,71%为白人,11%为黑人)中,NT-proBNP 与 eGFR 呈负相关,肾功能越受损,相关性越强。每降低 15 个 eGFR 单位,eGFR<30 的 NT-proBNP 增加 4.3 倍;eGFR 为 30 至 60 的 NT-proBNP 增加 1.7 倍,eGFR 为 61 至 90 的 NT-proBNP 增加 1.4 倍,eGFR 为 91 至 120 mL/min/1.73 m 的 NT-proBNP 增加 1.1 倍。在中位 17.6 年的随访期间,发生了 2275 例死亡(622 例心血管死亡)。较高的 NT-proBNP 与全因死亡率(每加倍 NT-proBNP 的 HR:1.20,95%CI:1.16-1.25)和心血管死亡率(HR:1.34,95%CI 1.25-1.44)相关。各 eGFR 类别之间的相关性相似(P 交互作用>.10)。与 NT-proBNP<125 pg/mL 和 eGFR>90 mL/min/1.73m 的患者相比,NT-proBNP≥450 pg/mL 且 eGFR<60 mL/min/1.73m 的患者全因死亡率和心血管死亡率风险分别增加了 3.4 倍和 5.5 倍。
尽管 NT-proBNP 与 eGFR 呈强负相关,但在普通美国成年人的整个肾功能范围内,NT-proBNP 与死亡率仍存在很强的相关性。